Desogestrel
Brand names: Cerazette, Cerelle
Desogestrel is a progestogen used as a progestogen-only oral contraceptive ('mini-pill').
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It acts primarily by inhibiting ovulation, supplemented by thickening of cervical mucus to impede sperm penetration and changes to the endometrium.
Prescribing in practice
- Unlike traditional progestogen-only pills, desogestrel reliably suppresses ovulation, but a missed pill beyond the permitted window still requires additional contraceptive precautions and consideration of emergency contraception.
- It can be used in many women in whom oestrogen is contraindicated, including during breastfeeding.
- Irregular or unpredictable bleeding is the most common reason for discontinuation and should be discussed before starting.
Monitoring
No specific laboratory monitoring is required; assess blood pressure and review contraceptive needs and any new bleeding pattern at follow-up.
Counselling the patient
- Take one tablet at the same time each day without a break between packs.
- If a pill is taken late beyond the allowed window, use additional precautions such as condoms as advised.
- Irregular bleeding or spotting is common, especially in the early months.
Evidence & guidelines
Desogestrel-only contraception is recommended within UK guidance as an effective oestrogen-free option, including for breastfeeding women.
Reference: FSRH POP guideline; UKMEC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21